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ABSTRACT OF THE DISSERTATION
Effect of Passive Vibration in Skin Blood Flow, Skin Temperature and Blood Pressure In
Good Glycemic Control and Poor Glycemic Control Type 2 Diabetics
by
Kanikkai Steni Balan Sackiriyas
Doctor of Science, Graduate Program in Physical Therapy
Loma Linda University, March 2013
Dr. Everett B. Lohman, Chairperson
Microcirculation regulated by the sympathetic system and vascular endothelium
plays a significant role in the homeostasis of temperature and wound healing. Damage to
the autonomic nervous system and endothelial system resulting from aging and diabetes
decreases the potential of wound healing. Insulin resistance and impaired wound healing
associated with type 2 diabetes can lead to diabetic foot ulceration (DFU). Factors such
as the increased insulin resistance, impaired wound healing and DFU can increase the
risk of amputation in type 2 diabetics (T2D). In research, passive vibration (PV) was
effective in increasing skin blood flow (SBF) in healthy individuals as well as in good to
fair glycemic control T2D. There has been no study performed to examine the effect of
PV on (SBF), skin temperature (ST) and blood pressure (BP) in good glycemic control
(GG) control and poor glycemic (PG) control T2D. The purpose of this study was to
examine the effect of PV on SBF without adversely affecting the ST and BP in GG
control and PG control T2D. This was done by assessing SBF using a MOOR full-field
laser perfusion imager (MOOR FLPI) after the application of PV.
Seventeen good glycemic control and fifteen poor glycemic control T2D
participated in this study. The SBF, ST and BP were measured at the baseline. Then, the

xiv

subjects received PV to their calf area and foot area on another side for about ten
minutes. The second reading was measured immediately after the PV. The third
measurement was taken after a ten minutes rest post the vibration application.
Results from this study showed that PV significantly increased SBF in the calf
area from baseline to immediately after vibration and baseline to 10 minutes post rest
without adversely affecting the ST and BP in both GG control and PG control T2D.
Also, the percent change of SBF in the foot area was higher in the GG control (91.3%)
than in PG control T2D (32.6%).
Results from this study suggest that PV can be a safe and alternative method in
increasing SBF without increasing the risk of burns in GG control and PG control T2D.
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CHAPTER ONE
INTRODUCTION
Diabetes Mellitus (DM) is a common metabolic disorder in which the pancreatic
cells produce either no insulin or insufficient insulin, or the body cells do not respond to
the insulin that is produced. It results in abnormal metabolism of carbohydrates, fats and
proteins which leads to a high amount of glucose levels in the blood stream and in the
urine (1). Diabetes has become a major health care problem in the United States (2),
affecting millions of Americans each year (3). It is estimated that 25.8 million (8.3%)
children and adults in the United States have diabetes and 10.9 million (26.9%) of the
world population ≥65years have diabetes (1), (2). The Centers for Disease Control and
Prevention (CDC) estimated that diagnosed diabetes is likely to increase 165 percent by
2050 (1).
Diabetes is one of the leading causes of disability and death from stroke and heart
diseases. It is the seventh leading cause of death in the United States, according to a
report published by the CDC (1), (2). The fact sheet released by the National Diabetes
Information Clearinghouse reported that the care associated with diabetes has cost the
United States a total of $174 billion (indirect costs and direct costs)

(1), (2)

. The medical

expenses associated with diabetes are two times higher in diabetic individuals than in
non-diabetics (2). Diabetes Mellitus is divided into four major types: Type 1, Type 2,
Gestational, and Latent Autoimmune Diabetes in Adults (LADA) (1), (2), (3), (4).
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Type 1 diabetes is an autoimmune disease in which the body’s system for fighting
infection (the immune system) turns against the host cells. It attacks and destroys the
insulin producing beta cells in the pancreas, resulting in the production of little or no
insulin. Causes that are possibly associated with Type I diabetes include a T cell
mediated autoimmune attack, hereditary influence, environmental factors, and viruses.
Type 1 diabetes is most often present in children and the young adults (1), (4), (5).
Patients are categorized as prediabetes when their blood glucose level is higher
than the normal but lower than the level used for diagnosing diabetes. Thirty three
percent (1 in 3 Americans) of people having prediabetes are likely to develop type 2
diabetes within ten years if adequate steps are not taken (1), (2). In contrast, type 2 diabetes
is a non-autoimmune disease (6). Type 2 diabetes is the most common form (90% to 95%)
among all types of diabetes and is due to insulin resistance in which target cells do not
use the insulin effectively, even though normal, or in some cases elevated levels of
circulating endogenous insulin are present in the body. Eventually, insulin production
decreases after several years, leading to increased build up of glucose levels in the body
(1)

.
Gestational diabetes usually occurs late in the pregnancy due to associated

hormonal production or insulin shortage. Women with gestational diabetes have 40% to
60% chance of developing into type 2 diabetes within 5 to 10 years (1).
Latent autoimmune diabetes in adults (LADA) is also called type 1.5 diabetes or
double diabetes, because it shows combined signs of both type 1 and type 2 diabetes (1).
The LADA is an autoimmune disease and shows the clinical symptoms of type 1
diabetes. According to the Immunology of Diabetes Society, there are three diagnostic
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criteria for the LADA: 1) Adult age of onset (30 years of age); 2) presence of at least one
autoantibody (GAD, ICA, IAA or IA-2), and 3) insulin dependence for the first six
months after the diagnosis (7), (8).
Regardless of the type of diabetes mellitus (DM), there are numerous
complications associated with diabetes, including heart disease, stroke, high blood
pressure, blindness, kidney disease, neuropathy, poor circulation, foot ulcers and
amputation (2). The most common complication associated with diabetes is damage to the
microcirculation and endothelial cells (9). Damage to endothelial cells reduces their ability
to produce nitric oxide (NO) and decreases their sensitivity to NO, thereby leading to
decreased skin blood flow (10), (11). Microangiopathy due to defects in the structure and
function of the vessel wall, and impaired hemodynamic (hyper dynamic) circulation is a
common feature in diabetes. Anatomical impairments of the vessel wall can include
glycocalyx on the luminal side and protein deposition, smooth muscle cell proliferation
on the abluminal side. Impaired hemodynamics resulting from increased plasma volume
and viscosity, reduction in erythrocyte deformability, and aggregation of blood cells can
lead to microangiopathy, a common characteristic in diabetes (12), (13). Endothelial
glycocalyx reduces the internal diameter of the capillaries and reduces availability of
oxygen delivery to the tissues by as much as 60% (13), (14). Capillary rarefaction due to
hypertension in diabetes increases diffusion distance between capillaries and target cells,
slowing down diffusion rates of oxygen and glucose between those structures (13).

3

Blood Circulation
The entire blood circulation in the body is about 5-6 L/m at rest. A total of 4.75
L/m is distributed to the following organs; liver and kidneys 2,500 ml/min, skeletal
muscles 1,000 ml/min, brain 750 ml/min, heart 250 ml/min, and skin 250 ml/min
(thermo-neutral environments). The remaining cardiac output is delivered to other organs
(15), (16)

. Blood flow is regulated by factors such as arterial pressure, vascular resistance,

total peripheral resistance (TPR), blood viscosity, and length and radius of the blood
vessel. Blood flow increases proportionately with increasing arterial pressure and
decreases with vascular resistance. The principal factor in regulation of blood flow is the
radius of the vessel since all other factors do not change significantly in a healthy
individual. For example, a decrease in the diameter of the blood vessel to half of its size
increases resistance and reduces blood flow by 16 times when all other factors are
constant (15).
The vascular system is divided into larger conduit, medium resistance and smaller
micro vessels. Resistance vessels are responsible for maintaining blood pressure. Micro
vessels are entirely different from macro and medium vessels and represent “nutritive”
structures

(13), (17)

.

Regulation of Blood Pressure
Blood flow is regulated by two classes of mechanisms; those that are extrinsic,
and those that are intrinsic to the system proper. Extrinsic mechanisms act through the
autonomic nervous system and endocrine system, and produce more generalized effects
in many regions of the body. They directly affect resistance and blood flow. Intrinsic
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mechanisms within individual tissues have “built in” (localized) effects on vascular
resistance and blood flow. Intrinsic mechanisms regulate blood circulation through
myogenic and metabolic control (15).

Extrinsic Control
The autonomic nervous system controls blood flow through sympathetic (alphaadrenergic, beta-adrenergic) and parasympathetic (cholinergic) innervation. Endocrine
system controls blood flow through hormones such as Angiotensin II, Vasopressin
(ADH), Histamine, Bradykinens, and Prostaglandins (15).

Intrinsic Control
Intrinsic mechanisms control circulation through auto regulation. Autoregulation
through myogenic and metabolic regulation allows the organ to have some independent
control to maintain a constant blood flow rate despite variations in the systemic blood
pressure (15).

Skin Circulation
Skin circulation is a highly regulated mechanism that plays a vital role in the
regulation of blood pressure, temperature and healing, and is controlled by the central
nervous system and local metabolic states of tissues (16), (18), (19). Micro vessels consist of a
single terminal feeding arteriole that branch into a group of 15-20 smaller diameter
capillaries (13), (17). Microcirculation carries fuel and nutrients to remote cells and involves
in the exchange of waste products with the surrounding tissues. It is influenced by
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vascular permeability which in turn depends on the structure of vessel walls and existing
hydrostatic pressure differences between arteriolar and venular segments (13). The
metabolic, physical and nervous systems regulate the microcirculation. Therefore, not the
quantity but the distribution of blood in the micro vascular bed is a primary determinant.
A continuous change of blood flow in relation to amount, velocity and direction due to
local metabolic needs is finely regulated by vasoconstriction and vasodilation in the
microcirculation. This is achieved through the arteriolar myogenic response,
venoarteriolar reflex, and precapillary arteriolar vasomotion (13), (20). Failure in these
mechanisms can lead to hyperperfusion and subsequent hypertension in the micro
vascular bed.
The architecture of the micro vascular system is not uniform and varies in
glabrous (non hairy) and nonglabrous (hairy) skin (21). The glabrous skin (palms, soles,
lips, face, tips of fingers and toes) has numerous thick walled thermo-regulating
arteriovenous anastomoses (AVA) (22). It is mainly innervated by sympathetic
vasoconstrictor nerves (16), (21), (23), (24). Numerous larger diameter arterioles and venules in
these areas allow low resistance, high blood flow directly from the arterioles to venules
(16), (21), (25), (26), (27), (28)

. In contrast to that, the nonglabrous skin (dorsal area of hand, foot)

has more nutritive (NUTR) perfusion through small capillaries with fewer AVA and is
controlled by both the sympathetic vasoconstrictor and vasodilator nerves (24), (29). These
differences may lead to differential skin blood flow rates.
Capillaries in the microcirculation have only one single endothelial cell layer on
their basement membrane (13). Vascular endothelial cells are placed in between the blood
and surrounding vascular smooth muscles (30), (31). They secrete fat soluble chemicals such
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as vasodilators and vascular relaxation factors (27), (32). These chemicals diffuse into the
blood and the vascular smooth muscles, and the balance between these factors maintains
the normal skin blood flow. Any increase or decrease in these factors in one direction can
change the luminal size of the arterioles and thereby leading to increased or decreased
blood flow (27), (32), (33), (34), (35), (36).
Skin blood flow can be influenced by various factors such as tissue local pressure
and occlusion, temperature, moist heat, aging and diabetes, vitamins, body mass index
and race. Measuring SBF helps to understand the function of various organs and their
reaction to various stimuli and pharmacological interventions (37). Skin blood flow can be
measured by direct capillary pressure measurement, transcutaneous oxygen measurement,
radionuclide techniques, temperature (biopac thermostat, radiometric, thermography,
microwave radiometry and thermal clearance or conductivity measurements), ultrasound,
dermofluorometry, laser doppler flowmetry, photoplethysmography, and capillary
microscopy (38).

Vibration
Mechanical oscillations applied randomly or periodically are known as vibration.
Vibration can be applied to the whole body or to a specific region of the body. Vibration
can be divided into active and passive vibration. In active vibration, the mechanical
vibration is delivered horizontally to the body part and requires that the patient actively
participate in weight bearing and exercise (39).
Passive vibration does not require the patient to bear weight and the mechanical
oscillations are delivered perpendicularly with the subjects relaxed (39). Studies conducted
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on vibration reported changes associated with the vibration such as increased muscular
strength (40), (41), (42), (43), (44), improved muscle performance and balance (45), (46), (47),
increased muscle flexibility (48), increased body composition (42), (49), improvements in
human athletic performance such as running parameters and jumping, and improved
circulation (40), (47), (50), (51).
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Abstract
Objective
To study the effect of passive vibration on skin blood flow (SBF) in two groups of
diabetics: good control and poor control.

Materials and Methods
Passive vibration using Power Plate® was applied to the calf area and the plantar
surface of the foot. Fifteen good glycemic control (HbA1c < 7.5%) and twelve poor
glycemic control (HbA1c > 9%) type 2 diabetics participated in this study. The SBF was
measured using a MOOR full-field Laser perfusion imager before, immediately after
vibration and 10 minutes post the vibration application.

Results
There was a significant difference in the mean SBF for the calf area from baseline
to immediately after vibration in both good glycemic control and poor glycemic control
diabetics. The mean calf SBF was almost doubled in good glycemic control diabetics
from baseline (38.9 flux) to immediately after vibration (69.5 flux) (p=.03). The mean
calf SBF was more than doubled in poor glycemic control diabetics from baseline (32.9
flux) to immediately after vibration (77.9 flux) (p=.02). However, no significant change
in mean SBF was detected over time for the foot area in good glycemic control and poor
glycemic control diabetics (p<.05). Baseline resting SBF was higher in foot than calf area
for both good glycemic control and poor glycemic control type 2 diabetics. The percent
change from baseline to immediately after vibration in the calf SBF was higher in poor
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glycemic control (132.6%) than the good glycemic control diabetics (76%). Foot SBF
showed a higher percent increase in the good glycemic control (72.3%) than the poor
glycemic control diabetics (32.1%). The percent increase was 100.3% in the calf SBF and
55% in foot SBF irrespective of group.

Conclusion
In this study, we observed a significant change in mean calf SBF from baseline to
immediately after vibration. Also, the higher percent change of calf SBF and foot SBF
was observed from baseline to immediately after vibration. These results suggest that
passive vibration may be an effective therapy for increasing lower extremity circulation
in both good glycemic control and poor glycemic control type 2 diabetics.

Key Words
Vibration, MOOR FLPI, Skin Circulation, Good Glycemic Control, Poor Glycemic
Control, Diabetes Mellitus, Full-field Laser Perfusion Imager.
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Introduction
Diabetes Mellitus (DM) is a major health care problem and can lead to stroke and
heart disease (1). Millions of Americans are affected by DM. The associated medical
expenses and death rate is two times higher in diabetics than non-diabetics (1), (2). The
highest incidence of diabetes is known as type 2 diabetes (T2D) (90% to 95 %). This
typically results from the inadequate use of insulin by target cells even though circulating
insulin level maybe normal or elevated (1), (2), (3). According to the Center for Disease
Control and Prevention (CDC), DM is classified into good glycemic (HbA1c <7.5%), fair
glycemic (HbA1c ≥7.5% to ≤9%) and poor glycemic control (HbA1c >9%) based on the
Hemoglobin A1c (HbA1c) level (4), (5).

Circulation
Tissue healing is an intricate process and primarily depends on blood circulation
(6)

. Skin circulation is under the control of central nervous system and tissue’s metabolic

state (7). Resting skin blood flow is dependent on factors such as skin moisture, tissue
pressure, age, vitamins, race, diabetes, and exposure to free radicals (8).
Aging, body mass index (BMI) and diabetes affect endothelial cells and
autonomic function, hence decreases microcirculation (6), (9), (10). Complex architecture of
skin is responsible for differential circulation rate. Glabrous skin (palms, soles) has thick
walled arteriovenous anastomoses (AVA). Numerous larger arteries and venules in these
areas allow low resistance and high skin blood flow (SBF) rate. Whereas, non-glabrous
skin (forearm, calf, dorsal hand) has more nutritive (NUTR) perfusion and is served by
capillaries with fewer AVA (11), (12), (13).
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In research, vibration is being used to increase skin circulation. Research supports
the use of passive vibration (PV) to improve skin blood flow (SBF) without increasing
the risk of burns. Lohman et al., (2012) showed that PV significantly improved SBF in
hairy and non-hairy skin both in good to fair glycemic control diabetics and non-diabetics
(14), (15), (16)

. The purpose of this study was to examine the effect of PV on SBF in good

glycemic control versus poor glycemic control type 2 diabetics. We hypothesized that
passive vibration induced increase in SBF in calf and foot were higher in good glycemic
control than the poor glycemic control diabetics. The secondary hypothesis was that
passive vibration induced increase in SBF was higher in calf (non-glabrous) than the foot
(glabrous) in both good glycemic control and poor glycemic control type 2 diabetics.

Material and Methods
Study Population
Type 2 diabetics between the age ranges of 18-75 years invited to participate in
this study. Subjects with neurological disorders, orthopedic disorders, bleeding disorders,
leg ulcer, chronically exposed to vibration, cardiovascular diseases, deep vein thrombosis
(DVT), or pregnant were excluded. Thirty two subjects were recruited from the Diabetes
Support Group and from the Diabetes Treatment Center at Loma Linda University (LLU)
Medical Center. Five subjects were excluded because they did not meet the inclusion
criteria. Subjects were assigned into one of two groups: Good glycemic control diabetics
and Poor glycemic control diabetics. Both groups received passive vibration to their calf
area and the opposite foot area on the same day. The LLU’s institutional review board
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approved all procedures and subjects signed statements of informed consent (Appendix
A).
Instrumentation
A Physio Plate® (Domino S.R.L, San Vendemiano, Italy) was used to deliver
passive vibration at a frequency of 50 Hz for a total number of ten cycles (one cycle= 60s
working time: 2 s rest time) for a total of approximately ten minutes (Figure 1). A MOOR
full-filed Laser perfusion Imager (FLPI) (MOOR FLPI V 2.1, Oxford, England) was prewarmed for about 30 minutes to stabilize measurements and was used to measure SBF
non-invasively (Figure 2). The FLPI uses a red light laser beam applied perpendicularly
to capture SBF and blood flow was measured in “Flux” unit.

Figure 1. Physio Plate® vibration platform.
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Figure 2. MOOR Full-field Laser Perfusion Imager (FLPI).

Procedure
Screening
The testing room temperature was maintained at 71.6°F-75.2°F (22°-24° C) for
about 30 minutes before the subject enters. A 30 minutes rest period in supine position
was given to subjects to stabilize their blood flow before intervention. Subjects were
screened for exclusion and demographic data was collected (Appendix B). Subjects were
screened for possible DVT using the Well’s criteria (17). Subjects with a score of ≥2 (high
risk) were excluded.
Cutaneous sensation was checked using a Semmes-Weinstein Monofilament
(North Coast Medical, Inc, Morgan Hill, CA, USA) and the response, color of the handle
and notations were noted on the sensory foot mapping form (Appendix C). Vibration
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sense was checked with a 128 Hz tuning fork and subjects with a score of 2 (absent
sensation) were excluded.

Testing
Subjects were asked to lie prone on a plinth. A square shaped 3 cm x 3 cm area
was marked on the posterior aspect of the calf (muscle belly) and on the plantar aspect of
the first three (1-3) metatarsal heads to capture SBF. Baseline SBF was measured in the
calf area using the FLPI (Figure 3). Then, subjects received passive vibration to their calf
for ten minutes (Figure 4). The second reading was taken immediately after vibration.
Subjects were given a ten minutes rest before the third reading was taken. The same
procedures were repeated for foot on the opposite leg (Figure 5 & Figure 6).
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Figure 3. SBF measurement in the calf area.
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Figure 4. Calf area vibration.

Figure 5. Foot area vibration.
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Figure 6. SBF measurement in the foot area.

Data Analysis
Data was analyzed using SPSS version 20.0 (18). One sample Kolmogorov
Smirnov test was used to examine the distribution of the continuous variables. Chi-square
test of independence was used to compare the proportions of males & females, ethnicity
and levels of physical activity by group. We compared mean age and body mass index
(BMI) by group using independent t-test. Mixed factorial analysis of variance was used to
compare the effect of passive vibration on SBF from baseline to immediately after
vibration and 10 minutes post rest in good glycemic control and poor glycemic control
T2D subjects’ calf and foot. Significant differences were further examined with
Bonferroni test. The level of significance was set at p<.05.
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Results
Fifteen good glycemic control and twelve poor glycemic control type 2 diabetics
participated in the study. The results of the Kolmogorov Smirnov test showed the
distribution of age, BMI and SBF were approximately normal. There were no significant
differences between the good glycemic and poor glycemic control diabetics in terms of
gender, race, physical activity, age and BMI (p>.05) (Table 1).

Table 1. Distribution of demographic data by group (N=28).
Variables

Good (n=16)

Poor (n=12)

p-value

Male

9 (56.2%)

6 (50%)

.74

Female

7 (43.8%)

6 (50%)

White

7 (70%)

3 (30%)

Hispanic

4 (66.79%)

2 (33.3%)

Others¶

2 (33.3%)

6 (66.7%)

African American

2 (66.7%)

1 (33.3%)

Very light

3 (37.5%)

5 (62.5%)

Light

5 (71.4%)

2 (28.6%)

Moderate & Heavy

8 (61.5%)

5 (38.5%)

Age (Mean±SD)*

62.3±11.4

56.9±7.7

.17

BMI (Mean±SD)*

31.1±5.6

32.0±6.8

.71

Gender†

Ethnicity†

Physical activity†

†: Chi-square test
*: Independent t test
¶: Others: Asians, Middle eastern
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.49

.43

Good Glycemic Control
There was a significant change in mean calf SBF over time in good glycemic
control diabetics (F2, 30=6.71, p=.02) (Table 2). A significant change was seen between
baseline and immediately after vibration (p=.03) and between baseline and 10 minutes
post rest (p=.03). However, there was no significant change in mean foot SBF over time
in good glycemic control diabetics (F2, 30=2.6, p=.11). The mean SBF in the good
glycemic control was significantly higher in foot than in calf at baseline (137.5±22.4 vs
38.9±2.3; p<.001), immediately after vibration (187.0±29.2 vs 69.5±12.5; p<.001) and 10
minutes post rest (142.1±21.8 vs 66.8±11.6; p<.01) (Figure 7).

Figure 7. Changes in mean±SE† of SBF† by site in good glycemic control
diabetics over time.
†SBF: Skin blood flow
†SE: Standard error
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Poor Glycemic Control
There was a significant change in mean calf SBF over time in poor glycemic
control diabetics

(F2, 22=9.8, p=.01) (Table 2). A significant change was detected

between baseline and immediately after vibration (p=.02), between baseline and 10
minutes post rest (p=.01). There was no significant change in mean foot SBF over time in
poor glycemic control diabetics (F2, 30=.04, p=.91). The mean SBF in the poor glycemic
control was significantly higher in foot than in the calf at baseline (157.6±33.4 vs
32.9±2.6; p<.01), immediately after vibration (163.8±32.3vs 77.9±15.5; p=.03) and 10
minutes post rest (160.1±37.0 vs 70.9±12.5; p=.04) (Figure 8).

Figure 8. Changes in mean±SE† SBF† by site in poor glycemic control
diabetics over time.
†SBF: Skin blood flow
†SE: Standard error
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Table 2. Mean (SE†) skin blood flow over time by group and site.

Site

Group

Baseline

Immediately
after
vibration

Good

38.9(2.3)

69.5(12.5)

66.8(11.6)

.02

Poor

32.9(2.6)

77.9(15.5)

70.9(12.5)

.01

Good

137.5(22.4)

187.0(29.2)

142.1(21.8)

.11

Poor

157.6(33.4)

163.8(32.3)

160.1(37.0)

.91

Calf

Foot

10 min post
rest

p-value*

*Analysis of variance
†SE: Standard error

Good Glycemic Control vs. Poor Glycemic Control
There was a significant difference in mean calf SBF over time in both good
glycemic control and poor glycemic control diabetics (F2, 52=16.6, p=.001). However,
there was no significant difference between groups (F2, 30=.03, p=.90). Based on the
Bonferroni test, there was a significant difference in calf SBF between baseline and
immediately after vibration (p=.001) and between baseline and 10 minutes post rest
(p=.001) in both good glycemic control and poor glycemic control diabetics. There was
no significant difference in mean calf SBF between immediately after vibration and 10
minutes post rest (p=.40). There was no significant difference in foot SBF over time in
both good glycemic control and poor glycemic control diabetics (F2, 52=1.57, p=.22).

Discussion
The diabetic foot ulcer (DFU) is the leading cause of amputation in diabetics and
approximately 8% of diabetics tend to have peripheral vascular disease (PVD) at the time
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of initial diagnosis (19). Peripheral vascular disease rapidly rises with age and duration of
diabetes. The associated lower extremity amputation rate is 15 times higher in diabetics
than non diabetics. In most cases, the lesion starts from a painless trauma in an insensate
neuropathic foot. Healing of these lesions is thwarted by the presence of PVD. Lack of
sufficient blood flow and decreased delivery of leukocytes impairs the function of some
of tissue growth factors and antibiotics that are oxygen dependant, and increases the
growth of highly destructive anaerobes in the infected tissues (19). Therefore, modalities
that can increase even a small amount of circulation may play a clinically important role
in the healing process. Studies from the department of physical therapy in Loma Linda
University and others have shown that vibration can be effective in increasing SBF in
diabetics as well as in non-diabetics (14), (15), (16), (20), (21), (22), (23), (24), (25). We believe that the
increase in SBF may help in accelerating the healing process and the prevention of DFU.
Contrary to our expectation, the study results did not meet our first hypothesis;
there was no significant increase in SBF in the calf area and foot area in good glycemic
control than in poor glycemic control diabetics. On the other hand, the results from this
study supported our second hypothesis; SBF in the calf area was significantly increased
more than the foot area in both the good glycemic control and the poor glycemic control
diabetics as a result of passive vibration.
In this study, mean foot SBF was higher than the calf at baseline, immediately
after vibration and 10 minutes post rest in both good glycemic control and poor glycemic
control. One possible explanation could be that the arteriolar myogenic response,
vasoarteriolar reflex and precapillary arteriolar vasomotion in the microcirculation are
impaired. Normally, all these mechanisms regulate the blood flow during daily
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physiological stimuli such as local tissue metabolic needs and positional changes (upright
position). Upright position increases hydrostatic pressure in the leg that triggers sensors
in the vein to signal the arterioles to constrict. This phenomenon prevents excessive
perfusion in the capillaries and the subsequent hypertension. This very important
mechanism is deficient in both type 1 and type 2 diabetics (hemodynamic hypothesis) (26).
This could be the reason why we observed higher mean SBF, over time, in foot than calf
in both good glycemic control and poor glycemic control diabetics. This could also
possibly explain why there was no significant change in foot SBF overtime due to passive
vibration in both good glycemic control and poor glycemic control diabetics.
Precapillary arteriolar vasomotion is a phenomenon in which tissues show a
rhythmic, slow-wave and high amplitude changes in the arteriolar diameter. This
maintains the distribution of blood flowing through capillaries. Failure of this mechanism
may fill capillaries permanently and allows no further reserve when the demand is
increased. This function is impaired in many pathological conditions such as
hyperinsulinaemia (diabetes) (26). In this study, the percent change in calf SBF from
baseline to post vibration was significantly higher in poor glycemic control (132.6%)
than good glycemic control (76%) diabetics. There could be two possible explanations
for this finding. The possible explanation could be the absence of vasomotion due to
hyperinsulinaemia might be higher in poor glycemic control than good glycemic control
diabetics. This could be the reason why we observed higher percent change in the calf
area in poor glycemic control than in good glycemic control diabetics. On the other hand,
the absence of vasomotion is more common in foot than calf. This suggests that calf SBF
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in poor glycemic control might have responded well with the passive vibration. Further
studies have to be done to analyze this phenomenon.
The mean SBF in calf was almost doubled from baseline (38.9 flux) to
immediately after vibration (69.5 flux) in good control control and was more than
doubled from baseline (32.9 flux) to immediately after vibration (77.9 flux) in poor
glycemic control diabetics. This implies that passive vibration was effective in increasing
SBF in calf in both good glycemic control and poor glycemic control diabetics. However,
no considerable change in the calf SBF was observed from immediately after vibration to
10 minutes post rest in both good glycemic control and poor glycemic control diabetics.
This finding suggests that effect of passive vibration was maintained more than ten
minutes after the intervention.
Although significant SBF changes have been documented in the calf, PV for 10
minutes did not significantly increase skin blood flow in the foot; a common site of
diabetic ulcers. The percent change of foot SBF from baseline to immediately after
vibration was significantly higher in the good glycemic control (72.3%) as compared to
the poor glycemic control (32.1%) diabetics. Hyperinsulinaemia and associated impaired
vasomotion could be a possible reason why good glycemic control diabetics showed
higher calf SBF than the poor glycemic control diabetics. However, from a clinical
perspective, distribution of blood in the whole foot is an important factor although the
quantity of blood flow is less in micro-vascular bed (26). Therefore, a 72.3% increase in
the good glycemic control foot SBF and 32.1% increase in the poor glycemic control foot
SBF imply that passive vibration to the foot in both good glycemic control and poor
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glycemic control diabetics can be a good “head start” in maintaining healthy circulation
in foot.
In our study, we tried to minimize all the external factors that could mask the
effect of passive vibration. However, we did not stop the subjects from taking their blood
pressure and glucose control medications such as diuretics and metformin from a clinical
perspective. These medications could lower blood pressure (27) and might have masked
the effect of passive vibration. High fat meal also decreases blood flow (28) and may have
masked the vibration’s effect if subjects had high fat meal before vibration. Future studies
should focus on comparing the effect of vibration with and without high fat meal prior to
vibration. We did not record the subject’s physical activity just prior to the vibration
application although we recorded their general physical activity. Exercising before
vibration can increase or decrease the skin blood flow based on the training activity (29)
and thus may mask the effect of passive vibration. All of these factors could have
masked the real effect of passive vibration and can be avoided in the future studies.
Future studies can also examine whether assessing blood flow in the whole foot rather
than a single point for at least one minute. This would be helpful in understanding the
blood distribution in the micro-vascular bed.

Conclusion
Findings of higher mean calf SBF overtime in both poor glycemic control and
good glycemic control, higher percent change of calf SBF from baseline to immediately
after vibration in poor glycemic control than good glycemic control and higher percent
change of foot SBF from baseline to immediately after vibration in good glycemic
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control than poor glycemic control suggest that passive vibration can be safely applied to
maintain good circulation in the lower extremities. Although the observed increase in
foot was less in poor glycemic control, the distribution not the quantity plays a vital part
in the micro-vascular bed.
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Abstract
Objective
To study the effect of passive vibration on skin blood flow (SBF), skin
temperature (ST) and blood pressure (BP) in good glycemic control and poor glycemic
control type 2 diabetics.

Materials and Methods
Seventeen good glycemic control (HbA1c < 7.5%) and fifteen poor glycemic
control (HbA1c > 9%) type 2 diabetics received passive vibration to their calf and foot on
the same day. The SBF, ST and BP were measured before, immediately after vibration
and 10 minutes post the vibration application.

Results
There was a significant increase in the mean SBF in the calf from baseline to
immediately after vibration in the good glycemic control and the poor glycemic control
groups. The mean skin blood flow in the calf almost doubled from baseline (38.8 flux) to
immediately after vibration (67.5 flux) and 10 minutes post rest (65.1 flux) in the good
glycemic control diabetics (p=.02). The mean SBF in the calf more than doubled from the
baseline (31.7 flux) to immediately after vibration (73.4 flux) and 10 minutes post rest
(67.6 flux) in the poor glycemic control diabetics (p=.00). However, there was no
significant difference in mean foot SBF over time in both good glycemic control and poor
glycemic control diabetics. Baseline resting mean of SBF was higher in foot than in calf
for both groups of diabetics. The percent change in calf SBF was higher in the poor
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glycemic control (131.6%) than the good glycemic control diabetics (71.2%) from
baseline to immediately after vibration. However, foot SBF showed higher percent
increase in the good glycemic control (91.3%) than the poor glycemic control (32.6%)
diabetics from baseline to immediately after vibration. The percent increase was 99.5% in
the calf and 63.8% in the foot irrespective of group. There was no clinically significant
difference in the mean calf and foot ST and BP in both groups of diabetics.

Conclusion
Based on the results observed in this study, we suggest that passive vibration can
be safely administered to the calf area and the foot area without significantly increasing
the risk of burns, skin temperature and blood pressure in both good glycemic control and
poor glycemic control type 2 diabetics.

Key Words
Good Glycemic Control, Poor Glycemic Control, Diabetes Mellitus, Passive Vibration,
Skin Circulation, MOOR FLPI, Full-field Laser Perfusion Imager.
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ABBREVIATIONS
DM

Diabetes Mellitus

T2D

Type 2 Diabetics

HbA1c

Hemoglobin Assay A1c or Glycohemoglobin

CDC

The Centers for Disease Control and Prevention

BP

Blood Pressure

AVA

Arteriovenous Anastomoses

NUTR

Nutritive

SBF

Skin Blood Flow

BMI

Body Mass Index

NTS

Nucleus Tractus Solitarii

PV

Passive Vibration

ST

Skin Temperature

DVT

Deep Vein Thrombosis

LLU

Loma Linda University

FLPI

Full-field Laser Perfusion Imager

SPSS

Statistical Product and Service Solutions

ml

Milliliter

min

Minute

SBP

Systolic Blood Pressure

PVD

Diastolic Blood Pressure
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Introduction
Diabetes Mellitus (DM) is a major health care problem around the world.
According to the International Diabetes Federation, 371 million people are living with
diabetes around the globe. North America and the Caribbean spent more healthcare
dollars on diabetes than any other region in the world. The Unites States of America is
the third leading country with 24.1 million diabetics, with China (92.3 M) and India (63.0
M) being the top two countries with diabetes (1). Medical expenses and death rate are two
times higher in diabetics than non-diabetics (2), (3). Type 2 diabetes (T2D) is the most
common type of diabetes mellitus (90% to 95% of all forms of diabetes) and results from
the body’s inability to use the circulating insulin although circulating insulin level maybe
normal or in some cases elevated (2), (3), (4). Hemoglobin Assay A1c or Glycohemoglobin
is a reliable test that reflects the average control of glucose over the past three months (5).
According to the Centers for Disease Control and Prevention (CDC), DM can be
classified into good glycemic control (HbA1c <7.5%), fair glycemic control (HbA1c
≥7.5% to ≤9%) and poor glycemic control (HbA1c >9%), based on the Hemoglobin A1c
(HbA1c) level (6), (7).

Circulation
Skin circulation is a highly regulated phenomenon in response to various physical
and humoral stimuli (8). It plays a key role in the regulation of temperature (9), baroreflex
control of blood pressure (BP) (9) and tissue healing (10). The central nervous system and
the metabolic state of tissues controls the skin circulation (11). The architecture of the
micro vascular system is not uniform and varies in glabrous (non hairy) and nonglabrous
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(hairy) skin (12). The glabrous skin (palms, soles, lips, face, tips of fingers and toes) has
deeply located numerous thick-walled thermo-regulating arteriovenous anastomoses
(AVA) (13). It is mainly innervated by sympathetic vasoconstrictor nerves (9), (12), (14), (15).
Numerous larger diameter arterioles and venules in these areas allow low resistance,
high blood flow directly from the arterioles to venules (9), (12), (16), (17), (18), (19). In contrast to
that, the nonglabrous skin (dorsal area of hand, foot) has more superficial nutritive
(NUTR) perfusion through small capillaries with fewer AVA and is controlled by both
the sympathetic vasoconstrictor and vasodilator nerves (15), (20). These differences may
lead to differential SBF rates.
Resting skin blood flow in a thermoneutral environment is about 5%-10% of
cardiac output (250 mL/min) (9), (21). This is because of the dominant activity of the
vasoconstrictor system in thermoneutral environments (22). The skin reaches about 50%70% of cardiac output (6 to 8 L/min) during exercise or heat exposure (9), (21). The
sympathetic vasodilator system is not active during normothermia but activated only
during hyperthermia. The larger increase in the skin circulation during hyperthermia is
primarily achieved by activation of the sympathetic vasodilator nerves (80%-90%) and to
a smaller extent by withdrawal of the sympathetic vasoconstrictor nerves (10%-20%) (15),
(23), (9)

. Thus, subtle changes in the skin circulation play a crucial role in maintaining the

normal human temperature (homeostasis) through heat dissipation (cutaneous
vasodilation and sweating) and heat generation (9). For example, a rise of as little as 8 ml
per 100 ml/min over the entire body surface from the neutral level can double the heat
transfer to the environment (24).
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Aging, body mass index (BMI), and diabetes impair the function of endothelial
cells and autonomic nervous system, hence decreases microcirculation (10), (25), (26).
Inabilities of the blood vessels to vasodilate in type 2 diabetes impair the normal heat
dissipation and increase the risk of heat exhaustion (9), (27), (28). Researchers believe SBF
has no significant impact on the baroreflex control of BP unlike the skeletal muscles (29).
However, baroreceptor reflex is an important mechanism that rapidly adjusts BP changes.
Receptors in the carotid sinus and aortic arch carry the afferent information to the nucleus
tractus solitarii (NTS). Short interneurons connect the NTS to the dorsal motor nucleus of
the vagus and nucleus ambiquus (parasympathetic efferent), and rostral ventrolateral
medulla oblongate (sympathetic efferent). A rise in the BP stimulates the baroreceptors
and in turn increases the vagal tone and decreases the sympathetic tone. The opposite
happens when there is a decrease in the BP (30). In recent years, research studies
supported the role of sympathetic vasodilator and vasoconstrictor systems in the BP
regulation (21), (31), (32), (33), (34). For example, the skin vasoconstrictor system was active
when unloading of baroreceptors was achieved using lower-body negative pressure.
However, skin circulation is low in thermoneutral environments. During hyperthermia,
the vasodilator system is active and skin receives 50%-70% of cardiac output. Studies
show that skin vasoconstricts through withdrawal of the vasodilator system when lower
body negative pressure is applied during hyperthermia (21), (32). This implies that
sympathetic activity in skin plays an integrated role in thermoregulation and the
regulation of blood pressure. Impairment in one system can affect the other system (9).
In research, the use of passive vibration (PV) to improve skin blood flow (SBF)
without increasing the risk of burns has been performed and supported. A series of
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studies performed by Lohman et al and Maloney-Hinds et al showed that PV significantly
improved SBF in hairy and non-hairy skin in healthy volunteers, healthy older
individuals, good to fair glycemic control diabetics and non-diabetics (35), (36), (37), (38), (39),
(40)

. However, there was no research study examining the effect of PV in increasing SBF

in diabetics without affecting skin temperature and blood pressure. The purpose of this
study was to examine the effect of PV on SBF, skin temperature (ST) and blood pressure
(BP) in good glycemic control versus poor glycemic control diabetics. We hypothesized
that SBF in the calf area and the foot area without significantly affecting the skin
temperature and blood pressure would be higher in good glycemic control than in poor
glycemic control type 2 diabetics as a result of passive vibration.

Material and Methods
Study Population
Type 2 diabetics between the age ranges of 18-75 years were invited to participate
in this study. Subjects with neurological disorders, orthopedic disorders, bleeding
disorders, leg ulcer, chronically exposed to vibration, cardiovascular diseases, possible
deep vein thrombosis (DVT) with a score of 2 (high risk) in well’s criteria (41) or pregnant
were excluded. Thirty seven subjects were recruited through fliers and word of mouth,
and from the Diabetes Support Group and from the Diabetes Treatment Center at Loma
Linda University (LLU) Medical Center. Five subjects were excluded because they did
not meet the inclusion criteria. All the subjects were assigned to one of two groups:
Group 1=Good glycemic control and Group 2=Poor glycemic control. Subjects received
passive vibration to their calf and the opposite foot on the same day. All procedures were
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approved by the LLU’s institutional review board and each subject signed a statement of
informed consent (Appendix A).

Instrumentation
A Physio Plate® (Domino S.R.L, San Vendemiano, Italy) was used to deliver
passive vibration at a frequency of 50 Hz for a total number of ten cycles (one cycle= 60s
working time: 2s rest time) or approximately ten minutes (Figure 9). Skin blood flow was
measured non-invasively by using a MOOR Full-field Laser Perfusion Imager (FLPI)
(MOOR FLPI V 2.1, Oxford, England) that was pre-warmed for about 30 minutes
(Figure 10). It uses a red light laser beam (632.8 nm) applied perpendicularly to capture
SBF and the blood flow was measured in “Flux” unit. Skin temperatures were measured
using a thermistor placed on the muscle belly of posterior calf muscle and on the plantar
aspect of the first three metatarsal heads (Figure 11). The thermistor was manufactured
by BioPac systems (BioPac Inc., Goleta, CA) and the output was sensed by an SKT 100
thermistor amplifier. This analog data was converted into a digital data by the BioPac
systems (BioPac Inc., Goleta, CA). A mean temperature was taken to analyze the data.
Blood pressure at the brachial artery was measured using a blood pressure cuff monitor
(RITE AID, Camp Hill, PA) (Figure 12).
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Figure 9. Physio Plate® vibration platform.

Figure 10. MOOR FLPI.
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Figure 11. Thermistor.

Figure 12. Blood pressure measurement.
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Procedure
Screening
The testing room temperature was maintained between 71.6°F-75.2°F (22°-24° C)
for about 30 minutes before the subjects enters. Subjects were asked to take rest in supine
position for about 30 minutes to stabilize their blood flow before intervention. Subjects
were screened for exclusion and demographic data was collected (Appendix B).
Cutaneous sensation was assessed using a Semmes-Weinstein Monofilament
(North Coast Medical, Inc, Morgan Hill, CA, USA) and the response, color of the handle
and notations were noted on the sensory foot mapping form (Appendix C). Vibration
sense was assessed using a 128 Hz tuning fork and subjects with a score of 2 (absent
sensation) were excluded.

Testing
A square shaped 3 cm x 3 cm area was marked on the posterior aspect of the calf
(muscle belly) and on the plantar aspect of the first three (1-3) metatarsal heads while the
subjects were in prone position on a plinth. Baseline SBF, ST and BP was measured.
Then, subjects received passive vibration to their calf for about ten minutes (Figure 13).
The second reading was taken immediately after vibration. Subjects were given a ten
minutes rest before the third reading was taken. The same procedures were repeated for
foot on the opposite leg (Figure 14).
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Figure 13. Calf area vibration.

Figure 14. Foot area vibration.
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Data Analysis
Data was analyzed using SPSS version 20.0 (42). The distributions of the
continuous variables were examined using one sample Kolmogorov Smirnov test. The
proportions of males & females, ethnicity and levels of physical activity by group were
compared using chi-square test of independence. We compared mean age and body mass
index (BMI) by group using independent t-test. Mixed factorial analysis of variance was
used to compare the effect of passive vibration on SBF, ST and BP from baseline to post
vibration and 10 minutes post rest in good glycemic control and poor glycemic control
Type 2 diabetic subjects’ calf and foot. Significant differences were further examined
with Bonferroni test. The level of significance was set at p<.05.

Results
Seventeen good and fifteen poor glycemic control type 2 diabetics participated in
this study. The results of the Kolmogorov Smirnov test showed that the distribution of
age, BMI and SBF were approximately normal. Results showed that there were no
significant differences between the good glycemic control and poor glycemic control
diabetics in terms of gender, race, physical activity, age and BMI (p>.05) (Table 3).
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Table 3. Distribution of demographic data by group (N=32).
Variables

Good (n=17)

Poor (n=15)

p-value

Male

10 (58.8%)

7 (41.2%)

.49

Female

7 (46.7%)

8 (53.3%)

White

7 (63.6%)

4 (36.4%)

Others¶

3 (30%)

7 (70%)

Hispanic

4 (66.7%)

2 (33.3%)

African American

3 (60%)

2 (40%)

Very light

3 (30%)

7 (70%)

Light

6 (75%)

2 (25%)

Moderate & Heavy

8 (57.1%)

6 (42.9%)

Age (Mean±SD)*

61.5±11.5

56.1±7.2

.12

BMI (Mean±SD)*

30.7±5.6

32.3±6.5

.47

Gender†

Ethnicity†

Physical activity†

.37

.15

†: Chi-square test
*: Independent t test
¶: Others: Asians, Middle eastern

Skin Blood Flow
Good Glycemic Control
A significant change in mean calf SBF was observed over time in good glycemic
control diabetics (F2, 32=6.53, p=.02) (Table 4). A significant change was detected
between baseline and immediately after vibration (p=.03) and between baseline and 10
minutes post rest (p=.03). However, the mean foot SBF did not significantly changed
over time in good glycemic control diabetics (F2, 32=2.9, p=.09). The mean SBF was
significantly higher in foot than in calf in the good glycemic control at baseline
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(130.4±22.2 vs 38.8±2.2; p<.01), immediately after vibration (181.0±28.0 vs 67.5±12.0;
p<.001) and 10 minutes post rest (139.3±20.6 vs 65.1±11.0; p<.01) (Figure 15).

†

†

Figure 15. Changes in mean±SE SBF by site in good glycemic control
diabetics over time.
†SBF: Skin blood flow
†SE: Standard error

Poor Glycemic Control
A significant change in mean calf SBF was observed over time in poor control
diabetics (F2, 28=12.1, p=.01) (Table 4). A Significant change was observed between
baseline and immediately after passive vibration (p=.01) and between baseline and 10
minutes post rest (p=.01). There was no significant change in mean foot SBF over time in
poor glycemic control diabetics (F2, 28=.07, p=.86). The mean SBF was significantly
higher in foot than in calf in poor glycemic control at baseline (140.0±28.6 vs 31.7±2.3;
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p<.01), immediately after vibration (146.9±27.8 73.4±12.7; p=.03) and 10 minutes post
rest (145.1±31.0 vs 67.6±10.5; p=.03) (Figure 16).

Figure 16. Changes in mean±SE† SBF† by site in poor glycemic control
diabetics over time.
†SBF: Skin blood flow
†SE: Standard error
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Table 4. Mean (SE†) skin blood flow over time by group and site.

Site

Group

Baseline

Immediately
after
vibration

10 min post
rest

p-value*

Good

38.8(2.20)

67.5(12.0)

65.1(11.0)

.02

Poor

31.7(2.3)

73.4(12.7)

67.6(10.5)

<.01

Good

130.4(22.2)

181.0(28.0)

139.3(20.6)

.09

Poor

140.0(28.6)

146.9(27.8)

145.1(31.0)

.86

Calf

Foot
*Analysis of variance
†
SE: Standard error

Good Glycemic Control vs. Poor Glycemic Control
There was a significant difference in mean calf SBF over time in both good and
poor glycemic control diabetics (F2, 60=18.20, p<.001). Based on the Bonferroni test,
there was a significant difference in calf SBF between baseline and immediately after
vibration (p<.001) and between baseline and 10 minutes post rest (p<.001) in both good
glycemic control and poor glycemic control diabetics. There was no significant
interaction between calf SBF and group (F2, 60=.56, p=.49). In addition, there was no
significant difference between groups (F1, 30=.01, p=.97). There was no significant
difference in mean calf SBF between immediately after vibration and 10 minutes post
rest (p=.40). There was no significant difference in foot SBF over time in both good
glycemic control and poor glycemic control diabetics (F2, 60=2.0, p=.16). There was no
significant interaction between foot SBF and group (F2, 60=1.31, p=.27). Also, there was
no significant difference in mean foot SBF between groups (F1, 30=.04, p=.85).
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Skin Temperature
Good Glycemic Control
There was no significant change in mean calf ST over time in good glycemic
control diabetics (F2, 32=0.53, p=.50) (Table 5). However, a significant change was
detected in mean foot ST over time in good glycemic control diabetics (F2, 32=6.1, p<.01).
There was a significant change detected between baseline and immediately after vibration
(p=.02), and between immediately after vibration and 10 minutes post rest (p=.04). There
was a significant difference in mean ST between calf and foot in good glycemic control
diabetics at baseline (t16=5.2, p<.001), immediately after vibration (t16=4.8, p<.001) and
10 minutes post rest (t16=5.5, p<.001). The mean ST in the good glycemic control was
significantly higher in calf than in foot at baseline (88.5±0.8 vs 84.2±0.7; p<.001),
immediately after vibration (88.6±0.3 vs 85.6±0.6; p<.001) and 10 minutes post rest
(87.9±0.4 vs 84.6±0.7; p<.001) (Figure 17).
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Figure 17. Changes in mean±SE† ST† by site in good glycemic control
diabetics over time .
†SE: Standard error
†ST: Skin temperature

Poor Glycemic Control
There was no significant change in mean calf ST over time in poor glycemic
control diabetics (F2, 28=2.2, p=.13) (Table 5). Also, there was no significant change in
mean foot ST over time in poor glycemic control diabetics (F2, 28=2.5, p=.10). However,
there was a significant difference in mean ST between calf and foot in the poor glycemic
control diabetics at baseline (t14=3.4, p<.01), immediately after vibration (t14=2.7, p=.02),
and 10 minutes post rest (t14=3.1, p=.01). The mean ST in the good glycemic control was
significantly higher in calf than in foot at baseline (87.3±0.3 vs 84.8±0.8; p<.01),
immediately after vibration (88.0±0.4 vs 86.2±0.8; p=.02), and 10 minutes post rest
(87.5±0.5 vs 85.4±0.7; p<.01) (Figure 18).
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†

†

Figure 18. Changes in mean±SE ST by site in poor glycemic control
diabetics.
†SE: Standard error
†ST: Skin temperature

Table 5. Mean (SE†) skin temperature over time by group and site.

Site

Group

Baseline

Immediately
after
vibration

10 min post
rest

p-value*

Good

88.5(0.3)

88.0(0.4)

87.5(0.5)

.50

Poor

87.3(2.6)

77.9(15.5)

70.9(12.5)

.13

Good

84.2(0.7)

85.6(0.6)

84.6(0.7)

<.01

Poor

84.8(0.8)

86.2(0.8)

85.4(0.7)

.10

Calf

Foot
*Analysis of variance
†SE: Standard error
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Good Glycemic Control vs. Poor Glycemic Control
There was no significant difference in mean calf ST over time in both good
glycemic control and poor glycemic control diabetics (F2, 60=1.11, p=.31). Also, there was
no significant interaction between group and calf temperature (F2, 60=0.45, p=.55). There
was no significant difference between groups (F1, 30=1.79, p=.19). However, there was a
significant difference in mean foot ST over time in both good glycemic control and poor
glycemic control over time (F2, 60=7.3, p=.001). Based on the Bonferroni test, there was a
significant difference in foot ST between baseline and immediately after vibration
(p=.002) and between immediately after vibration and 10 minutes post rest (p=.04) in
both good glycemic control and poor glycemic control diabetics. There was no significant
interaction between foot ST and group (F2, 60=0.07, p=.93). There was no significant
difference in mean foot ST between groups (F1, 30=.54, p=.47).

Blood Pressure
Systolic Blood Pressure
Good Glycemic Control
There was no significant change in mean systolic blood pressure (SBP) over time
during calf vibration in good glycemic control diabetics (F2, 32=4.2, p=.06) (Table 6).
There was no significant change in mean SBP over time during foot vibration in good
glycemic control diabetics (F2, 32=.8, p=.44). There was a significant difference in mean
SBP between calf and foot in the good glycemic control diabetics at immediately after
vibration (p=.01). However, there was no significant difference in mean SBP between
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calf and foot in the good glycemic control at baseline (p=.23) and 10 minutes post rest
(p=.1).

Poor Glycemic Control
There was no significant change in mean SBP over time during calf vibration in
poor glycemic control diabetics (F2, 28=.5, p=.54) (Table 6). There was no significant
change in mean SBP over time during foot vibration in poor glycemic control diabetics
(F2, 28=.2, p=.76). There was no significant difference in mean SBP between calf and foot
in the good glycemic control diabetics at baseline (p=.83), immediately after vibration
(p=.65) and 10 minutes post rest (p=.13).

Table 6. Mean (SE†) systolic blood pressure over time by group and site.

Site

Group

Baseline

Immediately
after
vibration

Good

124.7(2.4)

131.8(4.5)

128.5(3.4)

.06

Poor

128.1(3.2)

128.7(4.7)

131.3(3.4)

.54

Good

122.5(2.3)

124.9(3.3)

124.7(2.4)

.44

Poor

127.7(4.0)

126.7(2.8)

128.1(3.2)

.76

Calf

Foot

10 min post
rest

p-value*

*Analysis of variance
†SE: Standard error

Good Glycemic Control vs. Poor Glycemic Control
There was no significant difference in mean calf SBP over time in both good
glycemic control and poor glycemic control diabetics (F2, 60=2.1, p=.15). Also, there was
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no significant interaction between group and calf SBP (F2, 60=1.5, p=.23). There was no
significant difference between groups (F1, 30=.1, p=.82). There was no significant
difference in mean foot SBP over time in both good glycemic control and poor glycemic
control diabetics (F2, 60=.3, p=.67). There was no significant interaction between foot SBP
and group (F2, 60=.5, p=.54). There was no significant difference in mean foot SBP
between groups (F1, 30=.8, p=.37).

Diastolic Blood Pressure
Good Glycemic Control
There was no significant change in mean diastolic blood pressure (DBP) over
time during calf vibration in good glycemic control diabetics (F2, 32=.9, p=.34) (Table 7).
There was no significant change in mean DBP over time during foot vibration in good
glycemic control diabetics (F2, 32=5.5, p=.39). There was no significant difference in
mean DBP between calf and foot in the good glycemic control at baseline (p=.53),
immediately after vibration (p=.29) and 10 minutes post rest (p=.36).
Poor Glycemic Control
There was no significant change in mean DBP over time during calf vibration in
poor glycemic control diabetics (F2, 28=4.8, p=.05) (Tabel 7). There was no significant
change in mean DBP over time during foot vibration in poor glycemic control diabetics
(F2, 28=1.0, p=.37). There was no significant difference in mean DBP between calf and
foot in the poor glycemic control diabetics at baseline (p=.11) and immediately after
vibration (p=.50). However, there was a significant difference between calf and foot at 10
minutes post rest (p=.02) (Figure 2).
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Table 7. Mean (SE†) diastolic blood pressure over time by group and site.

Site

Group

Baseline

Immediately
after
vibration

Good

74.1(1.7)

75.8(1.8)

75.6(1.5)

.43

Poor

79.6(1.8)

78.7(1.4)

83.3(1.8)

.05

Good

73.2(1.2)

74.2(1.4)

74.1(1.7)

.39

Poor

77.7(2.0)

80.1(1.7)

79.6(1.8)

.37

Calf

Foot

10 min post
rest

p-value*

*Analysis of variance
†SE: Standard error
Good Glycemic Control vs. Poor Glycemic Control
There was no significant difference in mean calf DBP over time in both good
glycemic control and poor glycemic control diabetics (F2, 60=3.4, p=.07). Also, there was
no significant interaction between group and calf DBP (F2, 60=2.6, p=.08). However, there
was a significant difference between groups (F1, 30=7.2, p=.01). There was no significant
difference in mean foot DBP over time in both good glycemic control and poor glycemic
control diabetics (F2, 60=1.4, p=.26). There was no significant interaction between foot
DBP and group (F2, 60=.2, p=.83). However, there was a significant difference in mean
foot DBP between groups (F1, 30=7.4, p=.01).

Discussion
Body temperature, skin blood flow (SBF) and blood pressure (BP) measurements
can provide important information about the status of the cardiovascular and
thermoregulatory systems. They provide the body’s physiological status and their
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response to various stimuli such as physical activity, stress and environmental influences
(43)

. Studies from the Department of Physical Therapy in the Loma Linda University and

others have shown that vibration can be effective in increasing SBF in diabetics as well
as in non-diabetics (38), (36), (37), (35), (39), (44), (45), (46), (47).
Results of this study showed that the mean SBF in the hairy skin (calf) was
improved in both good glycemic control and poor glycemic control diabetics. This
improvement was detected from baseline to immediately after vibration, and from
baseline to 10 minutes post vibration intervention with no significant increase in the ST
and SBF. There was a significant difference in the mean DBP between the groups.
However, the mean difference is 5.3 mm of Hg and can be considered clinically not
significant. The increase in mean calf SBF was almost doubled between baselines (38.8)
to immediately after vibration (67.5) and to 10 minutes post rest (65.1) in the good
glycemic control diabetics. The increase in mean calf SBF was more than doubled from
baseline (31.7) to immediately after vibration (73.4) and to 10 minutes post rest (67.6) in
the poor glycemic control diabetics. However, the percent change in calf SBF was higher
in the poor glycemic control (131.6%) than the good glycemic control diabetics (71.2%)
between baseline to immediately after vibration. No significant difference in the mean
calf SBF between immediately after vibration to 10 minutes post rest in both the groups
were detected, suggesting that both groups responded to passive vibration similarly. The
calf SBF remained elevated at ten minutes post PV and was beginning to decline in both
the groups.
In contrast to the hairy skin (calf), the foot (non hairy) showed no significant
increase in mean SBF across time in and between both good glycemic control and poor
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glycemic control diabetics. However, the highest percent change in the foot SBF was
seen in good glycemic control (91.3%) as compared to poor glycemic control (32.6%).
Although the percent change is less in poor glycemic control, we agree with
Wiernsperger and Bouskela that distribution of blood in the microvascular bed is the
primary factor and not the quantity (8). The foot of the good glycemic control diabetics
showed a mean temperature difference of 1.2°F. A mean temperature change of 1.2°F
was not considered clinically significant although it was statistically significant. We did
not notice any clinically significant rise or fall in the mean systolic and diastolic blood
pressure in both groups.
These findings suggest that passive vibration can be used to improve SBF in the
calf and foot without the risk of increasing skin burns, heat exhaustion and cardiovascular
stress in both good glycemic control and poor glycemic control type 2 diabetics.

Conclusion
Based on the findings, we suggest that passive vibration can be safely
administered to calf and foot without increasing the risk of burns; heat exhaustion and
increase in blood pressure in both good glycemic control and poor glycemic control type
2 diabetics.
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CHAPTER FOUR
SUMMARY

Diabetes Mellitus
Diabetes Mellitus is a group of metabolic disorder resulting from no insulin or
decreased insulin production from the pancreas. This can impair carbohydrate, fat and
protein metabolism and leads to abnormal glucose levels in the blood stream (1). In some
instances, the body ineffectively use insulin produced by the pancreatic cells. This leads
to build up of abnormal glucose levels in blood stream instead of being absorbed by body
cells. Overtime, the beta cells in the body loses its ability to produce enough insulin for
the cells to absorb glucose, leading to insulin resistance (2). Aging and diabetes can
damage the autonomic nervous system and the endothelial lining of the blood vessels.
These damages reduce the release of vaso dilator substances such as prostacyclin and
nitric oxide (NO) (3), (4) . As a result, the balance between the vasodilators and
vasoconstrictors substances is impaired in the endothelial cells leading to increased
vasoconstriction. This reduces the resting skin blood flow (4). One of the important
functions of the skin is the regulation of temperature in the human body.
Thermoregulation helps to maintain the balance between heat generation and heat
dissipation during thermoneutral environment and during hyperthermia. This is achieved
by the sympathetic vasodilator and vasoconstrictor systems. The ability to vasodilate is
impaired in diabetes. This most likely reduces the ability of the blood vessels to dissipate
heat during elevated temperature in the environments (5).
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Impaired skin microcirculation can lead to decreased nutrients to the epidermis
and reduces the exchange of waste products with epidermis. Therefore, damage to micro
vascular bed and associated reduction in the skin circulation plays a significant role in the
insulin metabolism (6) and rate of wound healing (7).

Vibration
Vibration is an intervention that increases skin blood flow in the healthy and
diabetic individuals without increasing the risk of burns. The effect on the human body as
a result of vibration, is not only biomechanical but also physiological (8). Vibration can be
delivered parallel to the blood vessels (longitudinal) or lateral to the blood vessels
(perpendicular). This can cause shear stress to both the larger and smaller vessels.
Increased external pressures as a result of perpendicular vibration can damage endothelial
tissues on the blood vessels. One of the important effects of lateral vibration
(perpendicular) in small vessels (arterioles, capillaries, venules) is the deformation of the
blood vessels. Thus, vibration can change the shape of the blood vessels from circular
into more or less elliptical. This change of shape from circular to elliptical can increase
total peripheral resistance (TPR).
A study performed by Mester et al., (2006) showed that the TPR was significantly
reduced after the application of vibration (8). Mester et al., (2006) suggested that the
decrease in TPR during vibration can be achieved by opening of more capillaries or
dilatation of blood vessels or both (8). Mester et al., (2006) proposed that safety during
the application of therapeutic vibration should be considered to avoid various damages
that may cause headache, internal bleeding or even death (8). This can be avoided by
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following the guidelines associated with vibration parameters. However, more research
studies have to be done to establish guidelines for parameters such as the frequency,
amplitude, duration of the each vibration application, resting interval, total duration of the
vibration application and position of the body.

Studies form the Department of Physical Therapy
A series of studies have been conducted from the Department of Physical
Therapy, Loma Linda University (LLU) to examine the effect of a specific frequency and
specific time in improving SBF due to active and passive vibration in healthy, diabetic
and non diabetic individuals.
In the first study, forty five healthy subjects aged between 18-43 years
participated and were randomly divided into one of three groups: Group 1=isometric
weight bearing exercise (vibration exercise), Group 2=exercise only and Group
3=vibration only. Initial baseline SBF was measured using a laser Doppler imager
produced by MOOR Instruments, Inc (LDV 304, Oxford, England). Then, the subjects
according to their assigned group performed isometric therapeutic exercise with or
without whole body vibration or received vibration to their calf using Power Plate®
vibration platform (Power Plate® North America, LLC, Culver City, California, USA).
Skin blood flow was measured immediately after the intervention. The third measurement
was taken after ten minutes of rest. The authors reported that the group that received
vibration only showed significant increase in blood flow from baseline to post vibration
(250%) and remained elevated at 10 minutes post intervention (200%) (9).
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In the second study, the authors utilized two experiments to assess if a specific
frequency or a specific duration of vibration was better in improving SBF. In first
experiment, they selected 18 healthy subjects (mean age 20.3±2.9 years) and randomly
placed them into 30Hz or 50Hz vibration group. In the second experiment, seven subjects
(mean age 23.3±3.8 years) received 30 Hz vibration on one day and were asked to come
the next day to receive 50 Hz. In both of these experiments, subjects received vibration to
the underside of their forearm for 10 minutes using a vibration platform (Power Plate®
North America, LLC, Culver City, California, USA). Subjects were instructed not to have
eaten two hours prior to the vibration intervention. Skin blood flow was measured using
laser Doppler flow meter (BioPac Systems, Golletta, CA) at baseline, during vibration
and 15 minutes of recovery period.
Findings from the first experiment showed that SBF remained significantly
elevated from fourth minute until the ninth minute in both 30Hz and 50Hz group. There
was a significant decrease (90%, p=0.01) in SBF between the ninth minute to tenth
minute of vibration. In addition to that, the fifth minute showed the highest percent
increase in 50Hz (511%) vs. 30Hz (360%) groups. During the 15 minutes recovery
period, SBF in the 30Hz group dropped below baseline (mean=78%) at the ninth minute
and reached its lowest point (mean=74%) at the 15 minute recovery period. However,
SBF in the 50Hz group did not return to the baseline (mean=128%) within the 15 minute
recovery.
Results of the second experiment showed that significant increase was seen at the
fourth minute in both 30Hz (293%) and 50Hz (513%) frequencies. Skin blood flow was
higher throughout the vibration treatment and two minutes after. Skin blood flow in the
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30Hz reached baseline (99%) at minute 5 of recovery, increased to 184% at minute 6. It
continued to drop after ninth minute and reached to 65% of baseline at minute 15 of
recovery. However, SBF in 50 Hz did not return to baseline (140%) and remained
elevated during the 15th minute recovery period. Study findings from these two
experiments suggested that passive vibration with a frequency of either 30 Hz or 50 Hz
can significantly increase skin blood flow in the forearm within five minutes of passive
vibration application. Based on the two experiments, the authors reported that passive
vibration was quick and a feasible method to increase skin blood flow in a short period of
time as opposed to the other methods that can lead to skin burns (hot packs), side effects
(medications) or discomfort (exercise) (10).
In another study, ten type 2 diabetics with an average HbA1c level of 6.5% and
ten age and body mass index (BMI) matched healthy adults, were tested. Subjects
received vibration to their forearm using the Power Plate® (Power Plate® North America,
LLC, Culver City, California, USA). Skin blood flow and blood concentrations of nitric
oxide (NO) were measured at baseline, immediately after 5 minutes of vibration and 5
minutes after vibration was ceased. Skin blood flow was measured by using a laser
Doppler meter (BioPac Systems, Golletta, CA). Results from this study showed that SBF
was significantly increased in both healthy adults (461%) and type 2 diabetics (223%).
Blood concentrations of NO was significantly higher in both the healthy group (374%)
and the type 2 diabetics (258%) without any significant difference between the two
groups (11).
In another study, ten healthy adult volunteers aged between 20-30 years
participated, and received two interventions a day for 3 consecutive days: Intervention 1 -
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active vibration only (vibration exercise), Intervention 2-passive vibration only,
Intervention 3 - moist heat only, Intervention 4 – moist heat combined with passive
vibration (MHPV), Intervention 5 – a commercial Sunbeam® Health at Home®
massaging heating pad, and Intervention 6 - no intervention, rest. Power Plate® (Power
Plate® North America, LLC. Culver City, California, USA) was used to deliver vibration.
Skin blood flow and skin temperature was measured on the posterior aspect of the muscle
belly of gastrocnemius at baseline, immediately after vibration and 10 minutes post
vibration. Skin blood flow and skin temperature were measured using a laser Doppler
flow meter produced by BioPac, Inc (BioPac Systems, Golletta, CA). The MHPV
combination showed highest increase in SBF than in the passive vibration alone and
moist heat alone groups from baseline to immediately after vibration. At the same time,
increase in skin temperature was lowest in the MHPV combination group than in passive
vibration alone and the moist heat alone groups. However, the passive vibration alone
group showed significant increase in skin blood flow without significant increase in skin
temperature as opposed to the moist heat alone group. These findings indicated that
passive vibration can be a safe alternative method in increasing SBF in individuals at a
greater risk of a burn (12).
In the follow up study, ten healthy elderly subjects between 55-73 years of age
received two interventions for ten minutes each day for three consecutive days:
Intervention 1- active vibration, Intervention 2- passive vibration, Intervention 3 – moist
heat, Intervention 4 – moist heat combined with passive vibration (MHPV), Intervention
5 – a commercial Sunbeam® Health at Home® Massaging Heating Pad, and Intervention
6- rest. Passive vibration was delivered using the Physio Plate® (GLOBUS Physio Plate,
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Domino S.R.L, San Vendemiano, Italy). Skin blood flow was measured using a laser
Doppler imager (MOOR FLPI, V 2.1. Oxford, England). Skin temperature was measured
using a thermistor (BioPac®, Inc, Goleta, California). Measurements were taken at
baseline, immediately after vibration and 10 minutes post vibration. Results showed that
the MHPV combination significantly increased SBF to 450% immediately after ten
minutes of vibration and to 379% at 10 minutes post rest; more than any other
interventions. A significant change in ST was found in the MHPV combination than the
other interventions. Findings from this study showed that passive vibration can increase
skin blood flow without increasing skin temperature in elderly individuals (13).
In another study, the authors examined the effect of PV with a frequency of 50
HZ in improving skin blood flow in type 2 diabetics. Eighteen subjects with type 2
diabetes mellitus between 47-74 years of age, and 18 age matched controls between 5075 years of age received 10 minutes of PV. Passive vibration was delivered to the anterior
aspect of their forearm and on the plantar aspect of the first three metatarsal heads using a
vibration platform (GLOBUS Physio Plate, Domino S.R.L, San Vendemiano, Italy). Skin
blood flow was measured at baseline, post vibration and 10 minutes post rest using a laser
Doppler imager (MOOR FLPI, V 2.1. Oxford, England). Findings showed that there was
a significant difference in the foot and forearm SBF across time for both groups.
Diabetics showed the greatest percent increase in the foot SBF (118.5%) from baseline to
end of vibration vs. non diabetics (37.62%). However, there was no significant change in
mean SBF in forearm vs. foot across time between groups. Study findings suggested that
passive vibration can increase SBF in type 2 diabetics (14).
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Conclusion
Overall, the study findings from the Department of Physical Therapy, LLU
suggest that: 1) Passive vibration is a safe method as opposed to other methods such as
hot packs, medications and exercise in increasing skin blood flow in the individuals who
are at a greater risk of burns, 2) Passive vibration can increase skin blood flow in healthy
younger adults, healthy elderly and type 2 diabetics, 3) Passive vibration can significantly
increase SBF in the forearm and foot with the subjects in the sitting position and in the
calf area with the subjects in the lying position, 4) Significant increase in SBF can be
obtained within five minutes of vibration, 5) SBF can remain elevated for at least nine
minutes during the vibration application, 6) SBF remains elevated for at least seven
minutes following the vibration application, and 7) The combination of moist heat and
passive vibration can significantly increase SBF in the calf area without significantly
increasing skin temperature.
Several lines of evidence suggest that clinicians can use passive vibration to
improve skin microcirculation (6), (9), (10), (11),

(12), (13), (14)

. This may reduce ulcer and other

skin complications that are associated with aging and diabetes. Clinical trials are needed
to determine the possibility of reducing diabetic ulcer as a result of passive vibration.

75

References
1.

Sales PM, Souza PM, Simeoni LA, Silveira D. alpha-Amylase inhibitors: a
review of raw material and isolated compounds from plant source. J Pharm Pharm
Sci. 2012;15(1):141-83.

2.

National Diabetes Clearinghouse. (January 22, 2013). Insulin Resistance and
Prediabetes. Retrieved March 22, 2013 from
http://diabetes.niddk.nih.gov/dm/pubs/insulinresistance/index.aspx.

3.

McLellan K, Petrofsky JS, Zimmerman G, Lohman E, Prowse M, Schwab E, et
al. The influence of environmental temperature on the response of the skin to
local pressure: the impact of aging and diabetes. Diabetes Technol Ther. 2009
Dec;11(12):791-8.

4.

Petrofsky JS. Resting blood flow in the skin: does it exist, and what is the
influence of temperature, aging, and diabetes? J Diabetes Sci Technol. 2012
May;6(3):674-85.

5.

Charkoudian N. Skin blood flow in adult human thermoregulation: how it works,
when it does not, and why. Mayo Clin Proc. 2003 May;78(5):603-12.

6.

Wiernsperger NF, Bouskela E. Microcirculation in insulin resistance and diabetes:
more than just a complication. Diabetes Metab. 2003 Sep;29(4 Pt 2):6S77-87.

7.

Watkins PJ. The diabetic foot. BMJ. 2003 May 3;326(7396):977-9.

8.

Mester J, Kleinoder H, Yue Z. Vibration training: benefits and risks. J Biomech.
2006;39(6):1056-65.

9.

Lohman EB, 3rd, Petrofsky JS, Maloney-Hinds C, Betts-Schwab H, Thorpe D.
The effect of whole body vibration on lower extremity skin blood flow in normal
subjects. Med Sci Monit. 2007 Feb;13(2):CR71-6.

10.

Maloney-Hinds C, Petrofsky JS, Zimmerman G. The effect of 30 Hz vs. 50 Hz
passive vibration and duration of vibration on skin blood flow in the arm. Med Sci
Monit. 2008 Mar;14(3):CR112-6.

11.

Maloney-Hinds C, Petrofsky JS, Zimmerman G, Hessinger DA. The role of nitric
oxide in skin blood flow increases due to vibration in healthy adults and adults
with type 2 diabetes. Diabetes Technol Ther. 2009 Jan;11(1):39-43.

12.

Lohman EB, 3rd, Bains GS, Lohman T, DeLeon M, Petrofsky JS. A comparison
of the effect of a variety of thermal and vibratory modalities on skin temperature
and blood flow in healthy volunteers. Med Sci Monit. 2011 Sep;17(9):MT72-81.

76

13.

Lohman EB, Sackiriyas KSB, Bains G, Calandra G, Lobo C, Nakhro D, et al. A
comparison of whole body vibration and moist heat on lower extremity skin
temperature and skin blood flow in healthy older individuals. Med Sci Monit.
2012;18(7):CR415-24.

14.

Lohman EB, Sackiriyas KS, Bains G, Dhamane KH, Solani KJ, Raju C, K., et al.
Effect of Vibration on Skin Blood Flow in Type 2 Diabetes Mellitus (accepted).
ijpot. 2013.

77

APPENDIX A
INFORMED CONSENT

78

79

80

81

APPENDIX B
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Demographic Data
Informed Consent:

Yes

Subject Identification Number:
Age:
Gender:
Physical Activity:

No

(Circle Correct Response)

Height:

Weight:

Very Light/ Light/ Moderate/ Heavy/ Exceptional

Ethnicity: American Indian or Alaska Native/ Asian/ Black or African American/ Hispanic or Latino/ Native
Hawaiian or Other Pacific Islander/ White/ Other:
Exclusion

Comments

Circulatory disorders
Deep vein thrombophlebitis or other bleeding disorders
Pregnant
Is it possible that you may be pregnant
Pacemakers
Cancer
History of Heart Disease
Skin Ulcers
Neurological or Orthopaedic Disorders

Yes (
Yes (
Yes (
Yes (
Yes (
Yes (
Yes (
Yes (
Yes (

Homan’s Sign Test
Assess for pain, pallor, swelling, tenderness or warmth to palpation:

+
Yes

Calf muscle girth

Left:

Right:

in/cm

)
)
)
)
)
)
)
)
)

No (
No (
No (
No (
No (
No (
No (
No (
No (
‐
No
in/cm

Well’s Clinical Prediction Rule for Deep Vein Thrombosis

Score

Active cancer?
Bedridden recently 3 days or major surgery within four weeks?
Calf swelling 3 cm compared to the other leg
Collateral (non‐varicose) superficial veins present?
Entire leg swollen?
Localized tenderness along the deep venous system?
Pitting edema, greater in the symptomatic leg?
Paralysis, paresis, or recent plaster immobilization of the lower extremity
Previously documented DVT?
Alternative diagnosis to DVT as likely or more likely
A score of ≥2 will be excluded from the study.

Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (1 Points)
Yes (‐2 Points)

Total Score:

Semmes‐Weinstein Test®: At test site location
2.83
3.61
4.31
4.56

5.07

(Circle one response)
6.65

□

Exclude in the study

A1c Level:
Decision :

□ Include in the study
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)
)
)
)
)
)
)
)
)

APPENDIX C
FOOT MAPPING FORM
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Semms-Weinstein Monofilament – Sensory Foot Mapping
Subject Number:
Foot ‐ dorsal

Foot ‐ plantar

Evaluator size

Target Force (g)

Representation

Dorsal Thresholds

PlantarThresholds

2.83
3.61

0.07
0.4

Green
Blue

Normal
Normal

4.31

2.0

Purple

4.56

4.0

Red

5.07

10.0

Red

6.65

300.0

Red

Normal
Diminished
light touch
Diminished
protective
Loss of
protective
Loss of
protective
Deep pressure
only

Impressions:
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Diminished
light touch
Diminished
protective
Loss of
protective
Deep pressure
only

